RESÚMENES ABRIL 2009

.

Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3! - Mortality and tardive dyskinesia: long-term study using the US National Death Index

Charles E. Dean, Paul D. Thuras

The British Journal of Psychiatry (2009) 194: 360-364

 

Gratis 4 - Maintenance of Response with Atypical Antipsychotics in the Treatment of Schizophrenia: a Post-hoc Analysis of 5 Double-blind, Randomized, Clinical Trials

Virginia Stauffer, Haya Ascher-Svanum, Lin Liu, Tamara Ball and Robert Conley

BMC Psychiatry 2009, 9:13

 

3< - Aripiprazole Prescribing Patterns and Side Effects in Elderly Psychiatric Inpatients

Coley, Kim C; Scipio, Tina M; Ruby, Christine; Lenze, Eric J; Fabian, Tanya J

Journal of Psychiatric Practice: March 2009 - Volume 15 - Issue 2 - pp 150-153

 

GRATIS 3! - Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments

Paul M. Thompson, George Bartzokis, Kiralee M. Hayashi, Andrea D. Klunder, Po H. Lu, Nancy Edwards, Michael S. Hong, Michael Yu, Jennifer A. Geaga, Arthur W. Toga, Cecil Charles, Diana O. Perkins, Joseph McEvoy, Robert M. Hamer, Mauricio Tohen, Gary D. Tollefson, Jeffrey A. Lieberman and the HGDH Study Group

Cerebral Cortex 2009 19(5):1107-1123

 

3 - Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment

S. E. Chua, Y. Deng, E. Y. H. Chen, C. W. Law, C. P. Y. Chiu, C. Cheung, J. C. H. Wong, N. Lienenkaëmper, V. Cheung, J. Suckling and G. M. McAlonan

Psychological Medicine (2009), 39 : 793-800

 

3! - Body composition in psychotic disorders: a general population survey

S. E. Saarni, S. I. Saarni, M. Fogelholm, M. Heliövaara, J. Perälä, J. Suvisaari and J. Lönnqvist

Psychological Medicine (2009), 39:801-810

 

3 - The use of ziprasidone in clinical practice: Analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Friederike Vogel, Reinhard Gansmüller, Thomas Leiblein, Otto Dietmaier, Hans Wassmuth, Gerhard Gründer and Christoph Hiemke

European Psychiatry. Volume 24, Issue 3, April 2009, Pages 143-148      

 

5< - A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients




References and further reading may be available for this article. To view references and further reading you must purchase this article.

M. Riedel, F.X. Eich and H.J. Möller

European Psychiatry. Volume 24, Issue 3, April 2009, Pages 149-153      

 

3! - Belgian Schizophrenia Outcome Survey – Results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol




References and further reading may be available for this article. To view references and further reading you must purchase this article.

J. Peuskens, B. Gillain, D. De Graeve, B. Van Vleymen and A. Albert

European Psychiatry. Volume 24, Issue 3, April 2009, Pages 154-163      

 

3 - How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins




References and further reading may be available for this article. To view references and further reading you must purchase this article.

F.C.J. Starrenburg and J.P.A.M. Bogers

European Psychiatry. Volume 24, Issue 3, April 2009, Pages 164-170      

 

3 - Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Solrun Vidarsdottir, Ferdinand Roelfsema, Marijke Frolich and Hanno Pijl

Psychoneuroendocrinology. Volume 34, Issue 5, June 2009, Pages 705-712

 

3! - Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis

Constantin Psarros, Christos G. Theleritis, Thomas J. Paparrigopoulos, Antonios M. Politis, George N. Papadimitriou

International Journal of Geriatric Psychiatry. Volume 24 Issue 5, Pages 518 - 522

 

3! - McLean-Harvard International First-Episode Project: Two-Year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients

Paola Salvatore, Ross J. Baldessarini, Mauricio Tohen, Hari-Mandir K. Khalsa, Jesus Perez Sanchez-Toledo, Carlos A. Zarate, Jr., Eduard Vieta, and Carlo Maggini

J Clin Psychiatry 2009;70(4):458-466

 

3 - Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A Multicenter, Prospective, and Naturalistic Study

Marina Díaz-Marsá, Sara Sánchez, and Fernando Rico-Villademoros, for the ZIP-IIG-79 Study Group

J Clin Psychiatry 2009;70(4):509-517

 

3! - A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

John W. Newcomer, Robert E. Ratner, Jan W. Eriksson, Robin Emsley, Didier Meulien, Frank Miller, Julia Leonova-Edlund, Ronald W. Leong, and Martin Brecher

J Clin Psychiatry 2009;70(4):487-499

 

5< - A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

Deanna L. Kelly, Robert W. Buchanan, Douglas L. Boggs, Robert P. McMahon, Dwight Dickinson, Matthew Nelson, James M. Gold, M. Patricia Ball, Stephanie Feldman, Fang Liu, and Robert R. Conley

J Clin Psychiatry 2009;70(4):518-525

 

3 - Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial

Sidney Zisook, John W. Kasckow, Shahrokh Golshan, Ian Fellows, Ellen Solorzano, David Lehman, Somaia Mohamed, and Dilip V. Jeste

J Clin Psychiatry 2009;70(4):562-571

 

5 - A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

John M. Kane, Olawale Osuntokun, Ludmila A. Kryzhanovskaya, Wen Xu, Virginia L. Stauffer, Susan B. Watson, and Alan Breier

J Clin Psychiatry 2009;70(4):572-581

 

3 - Akathisia and second-generation antipsychotic drugs

Kumar, Rajeev; Sachdev, Perminder S

Current Opinion in Psychiatry: May 2009 - Volume 22 - Issue 3 - p 293-299

 

4 - Metabolic Changes Associated With Second-Generation Antipsychotic Use in Alzheimer's Disease Patients: The CATIE-AD Study

Ling Zheng, Wendy J. Mack, Karen S. Dagerman, John K. Hsiao, Barry D. Lebowitz, Constantine G. Lyketsos, T. Scott Stroup, David L. Sultzer, Pierre N. Tariot, Cheryl Vigen, and Lon S. Schneider

Am J Psychiatry Published April 15, 2009

4< - Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

Michael Davidson, Silvana Galderisi, Mark Weiser, Nomi Werbeloff, Wolfgang W. Fleischhacker, Richard S. Keefe, Han Boter, Ireneus P.M. Keet, Dan Prelipceanu, Janusz K. Rybakowski, Jan Libiger, Martina Hummer, Sonia Dollfus, Juan J. López-Ibor, Luchezar G. Hranov, Wolfgang Gaebel, Joseph Peuskens, Nils Lindefors, Anita Riechler-Rössler, and René S. Kahn

Am J Psychiatry Published April 15, 2009

3 - Prenatal Exposure to Maternal Infection and Executive Dysfunction in Adult Schizophrenia

Alan S. Brown, Sophia Vinogradov, William S. Kremen, John H. Poole, Raymond F. Deicken, Justin D. Penner, Ian W. McKeague, Anna Kochetkova, David Kern, and Catherine A. Schaefer

Am J Psychiatry Published April 15, 2009

GRATIS 3! - Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity

Nora D. Volkow

Schizophrenia Bulletin 2009 35(3):469-472

 

3! - Prenatal Malnutrition and Adult Schizophrenia: Further Evidence From the 1959-1961 Chinese Famine

Ming-Qing Xu, Wen-Sheng Sun, Ben-Xiu Liu, Guo-Yin Feng, Lan Yu, Lawrence Yang, Guang He, Pak Sham, Ezra Susser, David St. Clair and Lin He

Schizophrenia Bulletin 2009 35(3):568-576

 

3! - Relation of Schizophrenia Prevalence to Latitude, Climate, Fish Consumption, Infant Mortality, and Skin Color: A Role for Prenatal Vitamin D Deficiency and Infections?

Dennis K. Kinney, Pamela Teixeira, Diane Hsu, Siena C. Napoleon, David J. Crowley, Andrea Miller, William Hyman and Emerald Huang

Schizophrenia Bulletin 2009 35(3):582-595

 

3! - The Antecedents of Schizophrenia: A Review of Birth Cohort Studies

Joy Welham, Matti Isohanni, Peter Jones and John McGrath

Schizophrenia Bulletin 2009 35(3):603-623

 

3! - Association Between Paternal Schizophrenia and Low Birthweight: A Nationwide Population-Based Study

Herng-Ching Lin, Chao-Hsiun Tang and Hsin-Chien Lee

Schizophrenia Bulletin 2009 35(3):624-630

 

3! - Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia

Holger J. Sørensen, Erik L. Mortensen, June M. Reinisch and Sarnoff A. Mednick

Schizophrenia Bulletin 2009 35(3):631-637

 

3! - Life Events and High-Trait Reactivity Together Predict Psychotic Symptom Increases in Schizophrenia

Nancy M. Docherty, Annie St-Hilaire, Jennifer M. Aakre and James P. Seghers

Schizophrenia Bulletin 2009 35(3):638-645

 

3 - Remission in schizophrenia: analysis in a naturalistic setting




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jonas Eberhard, Sten Levander and Eva Lindström

Comprehensive Psychiatry. Volume 50, Issue 3, May-June 2009, Pages 200-208

 

3! - Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Andreas Johannes Schmidt, Ulrich Michael Hemmeter, Jürgen-Christian Krieg, Helmut Vedder and Philip Heiser

Journal of Psychiatric Research. Volume 43, Issue 8, May 2009, Pages 818-823

 

3! - Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action

Xavier López-Gil, Francesc Artigas and Albert Adell

The International Journal of Neuropsychopharmacology, Volume 12, Issue 04, May 2009, pp 487-499

 

3! - The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation
Zuo L, Luo X, Krystal JH, Cramer J, Charney DS, Gelernter J

Pharmacogenet Genomics. 2009 Apr 14. [Epub ahead of print]

 

3 - Subjective wellbeing under quetiapine treatment: Effect of diagnosis, mood state, and anxiety




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Martin Lambert, Dieter Naber, Anne Karow, Christian G. Huber, Jürgen Köhler, Joachim Heymann and Benno G. Schimmelmann

Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages 72-79

 

5 - Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Emilio Sacchetti, Alessandro Galluzzo, Paolo Valsecchi, Fabio Romeo, Barbara Gorini, Lewis Warrington and on behalf of the INITIATE Study Group

Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages 80-89

 

3! - Aripiprazole brain concentration is altered in P-glycoprotein deficient mice




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jun-Sheng Wang, Hao-Jie Zhu, Jennifer L. Donovan, Hong-Jie Yuan, John S. Markowitz, Mark E. Geesey and C. Lindsay DeVane

Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages 90-94

 

5< - Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Menahem Krakowski, Pal Czobor and Leslie Citrome

Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages 95-102

 

4 - Weight effects associated with antipsychotics: A comprehensive database analysis




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Bruce Parsons, David B. Allison, Antony Loebel, Kathryn Williams, Earl Giller, Steven Romano and Cynthia Siu

Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages 103-110

 

3 - Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Robert C. Smith, Jean-Pierre Lindenmayer, John M. Davis, James Cornwell, Kathryn Noth, Sanjay Gupta, Henry Sershen and Abel Lajtha

Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages 149-155

 

3! - Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder

MJ Müller, FX Eich, B Regenbogen, J Sachse, S Härtter, C Hiemke

Journal of Psychopharmacology, Vol. 23, No. 3, 278-286 (2009)

3 - Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial

M Zink, A Kuwilsky, B Krumm, H Dressing

Journal of Psychopharmacology, Vol. 23, No. 3, 305-314 (2009)

3 - WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics

Original Investigation

WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics

Steven M. Grauer, Radka Graf, Rachel Navarra, Amy Sung, Sheree F. Logue, Gary Stack, Christine Huselton, Zhi Liu, Thomas A. Comery, Karen L. Marquis and Sharon Rosenzweig-Lipson

Psychopharmacology. Volume 204, Number 1 / May, 2009: 37-48

 

3! - Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics

Original Investigation

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics

Xiang Yang Zhang, Dong Feng Zhou, Ling Yan Qi, Song Chen, Lian Yuan Cao, Da Chun Chen, Mei Hong Xiu, Fan Wang, Gui Ying Wu, Lin Lu, Therese A. Kosten and Thomas R. Kosten

Psychopharmacology. Volume 204, Number 1 / May, 2009: 177-184

 

3 - Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients

J Du, A Zhang, L Wang, J Xuan, L Yu, R Che, X Li, N Gu, Z Lin, G Feng, Q Xing, and L He

Journal of Psychopharmacology On Line First April 2009

 

3 - Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

Gerald Stober;  Dorit Ben-Shachar;  M. Cardon;  Peter Falkai;  Alfred N. Fonteh;  Micha Gawlik;  Birte Y. Glenthoj;  Edna Grunblatt;  Assen Jablensky;  Yong-Ku Kim;  Johannes Kornhuber;  Thomas F. McNeil;  Norbert Muller;  Bob Oranje;  Toshikazu Saito;  Mohamed Saoud;  Andrea Schmitt;  Michal Schwartz;  Johannes Thome;  Marat Uzbekov;  Nuria Durany; Peter Riederer

World Journal of Biological Psychiatry, Volume10, Issue 2 May 2009, pages 127 - 155

 

3 - Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: An open-label trial

Young-Chul Chung;  Chun-Rong Lee;  Tae-Won Park;  Keum-Hwa Yang; Ki-Won Kim

World Journal of Biological Psychiatry, Volume 10, Issue 2 May 2009, pages 156 - 162

 

3 - Untreated illness duration correlates with gray matter loss in first-episode psychoses

Bangalore, Srihari S; Goradia, Dhruman D; Nutche, Jeffrey; Diwadkar, Vaibhav A; Prasad, Konasale M.R; Keshavan, Matcheri S

NeuroReport: 6 May 2009 - Volume 20 - Issue 7 - pp 729-734

 

3! - Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison

Benedicto Crespo-Facorro, José M. Rodríguez-Sánchez, Rocío Pérez-Iglesias, Ignacio Mata, Rosa Ayesa, MariLuz Ramirez-Bonilla, Obdulia Martínez-Garcia, and José L. Vázquez-Barquero

J Clin Psychiatry April 21, 2009: e1-e13

 

3 - Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: A randomized, double-blind, crossover study in healthy adult subjects




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Catherine Datto, Lovisa Berggren, Jitendra B. Patel and Hans Eriksson

Clinical Therapeutics. Volume 31, Issue 3, March 2009, Pages 492-502

 

GRATIS 3 - An Epidemiologic Study of Psychotropic Medication and Obesity-Related Chronic Illnesses in Older Psychiatric Patients

Stephen Kisely, Martha Cox, Leslie Anne Campbell, Charmaine Cooke, David Gardner

Can J Psychiatry. 2009;54(4):269–274

 

GRATIS 3 - Improvement of Metabolic Risk Profile Under Second-Generation Antipsychotics: A Pilot Intervention Study

Mélissa Blouin, Mario Binet, Roch-Hugo Bouchard, Marc-André Roy, Jean-Pierre Després, Natalie Alméras

Can J Psychiatry. 2009;54(4):275–279

 

GRATIS 3 - Comorbid Cannabis Misuse in Psychotic Disorders: Treatment Strategies

Wilfrid Noël Raby

Primary Psychiatry. 2009;16(4):29-34

 

GRATIS 3! - Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics

OLIVEIRA, Irismar Reis de; NUNES, Paulo Menezes; COUTINHO, Domingos Macedo  and  SENA, Eduardo Pondé de

Rev. Bras. Psiquiatr. 2009, vol.31, n.1, pp. 52-56

 

3! – Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis

Baker RA et al.

Psychopharmacol Bull 2009; 42:11-31

.

Regresar a RESÚMENES ABRIL 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.